Cotransplantation of placental mesenchymal stromal cells enhances single and double cord blood engraftment in nonobese diabetic/severe combined immune deficient mice

Stem Cells

Volumn 27, Issue 9, 2009, Pages 2293-2300

  Hiwase, Smita D ^a,b   Dyson, Pamela G ^a   To, L Bik ^a,b   Lewis, Ian D ^a,b,c  

^a CENTRE FOR CANCER BIOLOGY   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

Chimerism; Cord blood transplantation; Double cord blood transplant; Engraftment; Placental mesenchymal stromal cells

Indexed keywords

CD34 ANTIGEN; CELL ANTIGEN; ENHANCED GREEN FLUORESCENT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CELL RENEWAL; CELL TRANSPLANTATION; CHROMOSOME ANALYSIS; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; ENGRAFTMENT; FEMALE; HUMAN; HUMAN TISSUE; MESENCHYME CELL; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; OUTCOME ASSESSMENT; PLACENTA; SCID MOUSE; STROMA CELL; UMBILICAL CORD BLOOD;

ANIMALS; ANTIGENS, CD34; CELLS, CULTURED; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; FETAL BLOOD; FLOW CYTOMETRY; HUMANS; KARYOTYPING; MALE; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED NOD; MICE, SCID; PLACENTA; PREGNANCY; STROMAL CELLS;

MUS;

EID: 70349862910     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.157     Document Type: Article

References (43)

1. McNiece IK, Almeida-Porada G, Shpall EJ et al. Ex vivo expanded cord blood cells provide rapid engraftment in fetal sheep but lack long-term engrafting potential. Exp Hematol 2002;30:612-616. (Pubitemid 34626658)
2. Barker JN, Weisdorf DJ, DeFor TE et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005;105:1343-1347.
3. Laughlin MJ, Eapen M, Rubinstein P et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004;351:2265-2275. (Pubitemid 39552742)
4. Brunstein CG, Barker JN, DeFor TE et al. Non-myeloablative (NMA) umbilical cord blood transplantation (UCBT): Promising disease-free survival in 95 consecutive patients. Blood 2005;106:559a.
5. Ding L, Lu S, Batchu R et al. Bone marrow stromal cells as a vehicle for gene transfer. Gene Ther 1999;6:1611-1616. (Pubitemid 29465520)
6. Gronthos S, Simmons PJ. The biology and application of human bone marrow stromal cell precursors. J Hematother 1996;5:15-23. (Pubitemid 26308990)
7. Dominici M, Le Blanc K, Mueller I et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy Position Statement. Cytotherapy 2006;8:315-317.
8. In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 2004;22:1338-1345.
9. Chang CJ, Yen ML, Chen YC et al. Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-gamma. Stem Cells 2006;24:2466-2477.
10. Portmann-Lanz CB, Schoeberlein A, Huber A et al. Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration. Am J Obstet Gynecol 2006;194:664-673. (Pubitemid 43333137)
11. Lewis ID, Almeida-Porada G, Du J et al. Umbilical cord blood cells capable of engrafting in primary, secondary, and tertiary xenogeneic hosts are preserved after ex vivo culture in a noncontact system. Blood 2001;97:3441-3449.
12. Quantitative analysis of chimerism after allogeneic stem cell transplantation using multiplex PCR amplification of short tandem repeat markers and fluorescence detection. Leukemia 2001;15:303-306. (Pubitemid 32175468)
13. Boggs DR. The total marrow mass of the mouse: A simplified method of measurement. Am J Hematol 1984;16:277-286.
14. Brunstein CG, Barker JN, Weisdorf DJ et al. Umbilical cord blood transplantation after nonmyeloablative conditioning: Impact on transplantation outcomes in 110 adults with hematologic disease. Blood 2007;110:3064-3070.
15. Gluckman E, Rocha V. Donor selection for unrelated cord blood transplants. Curr Opin Immunol 2006;18:565-570. (Pubitemid 44311457)
16. Wagner JE, Barker JN, DeFor TE et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002;100:1611-1618.
17. Gluckman E, Rocha V, Arcese W et al. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol 2004;32:397-407. (Pubitemid 38410917)
18. Kim DW, Chung YJ, Kim TG et al. Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation. Blood 2004;103:1941-1948.
19. Ball LM, Bernardo M, Roelofs H et al. Co-Transplantation of HLA-Haploidentical, bone marrow derived mesenchymal stem cells prevents graft failure and improves hematological recovery in T-cell depleted haploidentical stem cell transplantation. Blood 2007;110:3073a.
20. Macmillan ML, Blazar BR, Defor TE et al. Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: Results of a phase I-II clinical trial. Bone Marrow Transplant 2009;43:447-454.
21. Nauta AJ, Kruisselbrink AB, Lurvink E et al. Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/SCID mice by cotransplantation of a second unrelated cord blood unit. Exp Hematol 2005;33:1249-1256. (Pubitemid 41416974)
22. Noort WA, Kruisselbrink AB, in't Anker PS et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol 2002;30:870-878.
23. + cells in NOD/SCID mice. Blood 2007;110: 1416a.
24. Wang CY, Tan HT, Huang ZQ et al. Study on effect hemopiesis reconstituted of auto-mesenchymal stromal cells or allo-mesenchymal stromal cells transplantation. Blood 2007;110;5056a.
25. Zuk PA, Zhu M, Ashjian P et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002;13:4279-4295. (Pubitemid 35471185)
26. Burgess AW, Wilson EM, Metcalf D. Stimulation by human placental conditioned medium of hemopoietic colony formation by human marrow cells. Blood 1977;49:573-583. (Pubitemid 8080187)
27. + cells. Exp Hematol 2004;32:657-664.
28. Lu LL, Liu YJ, Yang SG et al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 2006;91:1017-1026.
29. Gronthos S, Zannettino AC, Hay SJ et al. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 2003;116:1827-1835. (Pubitemid 36582169)
30. Fukuchi Y, Nakajima H, Sugiyama D et al. Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells 2004;22:649-658. (Pubitemid 39166923)
31. Panepucci RA, Siufi JL, Silva WA, Jr. et al. Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells. Stem Cells 2004;22:1263-1278. (Pubitemid 39646504)
32. Bailo M, Soncini M, Vertua E et al. Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation 2004;78:1439-1448. (Pubitemid 39552929)
33. Koç ON, Gerson SL, Cooper BW et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 2000;18:307-316.
34. Shen BJ, Hou HS, Zhang HQ et al. Unrelated, HLA-mismatched multiple human umbilical cord blood transfusion in four cases with advanced solid tumors: Initial studies. Blood Cells 1994;20:285-292.
35. Kang HJ, Kho SH, Jang MK et al. Early engraftment kinetics of two units cord blood transplantation. Bone Marrow Transplant 2006;38:197-201.
36. Sordi V, Malosio ML, Marchesi F et al. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 2005;106:419-427. (Pubitemid 40981232)
37. Wynn RF, Hart CA, Corradi-Perini C et al. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 2004;104:2643-2645. (Pubitemid 39434942)
38. Lee RH, Hsu SC, Munoz J et al. A subset of human rapidly self-renewing marrow stromal cells preferentially engraft in mice. Blood 2006;107:2153-2161. (Pubitemid 43289401)
39. Yahata T, Ando K, Sato T et al. A highly sensitive strategy for SCID-repopulating cell assay by direct injection of primitive human hematopoietic cells into NOD/SCID mice bone marrow. Blood 2003;101:2905-2913. (Pubitemid 36857974)
40. Lataillade JJ, Clay D, Dupuy C et al. Chemokine SDF-1 enhances circulating CD34(+) cell proliferation in synergy with cytokines: Possible role in progenitor survival. Blood 2000;95:756-768. (Pubitemid 30062693)
41. Lataillade JJ, Clay D, Bourin P et al. Stromal cell-derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G(0)/G(1) transition in CD34(+) cells: evidence for an autocrine/paracrine mechanism. Blood 2002;99:1117-1129.
42. Peled A, Petit I, Kollet O et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 1999;283:845-848. (Pubitemid 129501124)
43. Muguruma Y, Yahata T, Miyatake H et al. Reconstitution of the functional human hematopoietic microenvironment derived from human mesenchymal stem cells in the murine bone marrow compartment. Blood 2006;107:1878-1887. (Pubitemid 43289366)